Entera Bio (ENTX) Assets Average (2018 - 2026)

Entera Bio (ENTX) has reported Assets Average for 7 consecutive years, with $14.6 million the latest figure, recorded in Q1 2026.

• Quarterly Assets Average fell 6.03% year-over-year to $14.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $14.6 million (down 6.03% YoY) and the FY2025 annual result came in at $12.7 million, up 19.99% from the prior year.
• Assets Average retreated to $14.6 million in Q1 2026 per ENTX's latest filing, from $16.7 million in the prior quarter.
• Over the last five years, Assets Average for ENTX reached as high as $24.1 million in Q1 2022 and fell as low as $8.6 million in Q4 2024.
• A 5-year average of $14.4 million and a median of $14.3 million in 2022 frame the typical range for Assets Average.
• Annual changes were most pronounced in 2023 — Assets Average slumped 48.79% — and 2025, when it jumped 108.56%.
• Year by year, Assets Average stood at $14.3 million in 2022, then slipped by 29.08% to $10.2 million in 2023, then slipped by 15.74% to $8.6 million in 2024, then soared by 94.97% to $16.7 million in 2025, then slipped by 12.81% to $14.6 million in 2026.
• According to Business Quant data, Assets Average over the past three periods registered $14.6 million, $16.7 million, and $18.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.